Jonathan Kamkhaji, Postdoctoral Research Fellow at University of Exeter, and Claudio Radaelli, Professor of Public Policy at UCL, argue that the surprising nature of the coronavirus crisis means governments cannot base their response on scientific evidence alone. Continue reading COVID-19: The presence and pitfalls of evidence-based policy
UCL Philosophy Professor James Wilson explores the philosophical public health implications of the coronavirus.
I’m a philosopher of public health. Like most philosophers, I generally tend to take my time in thinking about problems. Philosophers pride ourselves on the carefulness and disinterestedness of our reasoning about ethical principles – seeking to make recommendations impartially rather than on the basis of whim, or the feelings of the moment. Continue reading Philosophy & public policy: lessons from COVID-19
Brexit will have a significant impact on the NHS across multiple domains. Here, Marianthi Pappa, Researcher at the University of Aberdeen, outlines the impact of Brexit on the NHS workforce, financial resources for healthcare, public health, medicines and much more. Continue reading The Impact of Brexit on the NHS: Cure or Disease?
Doris cleaner to the chattering classes
A new UCL European Institute series of cartoons by Ros Asquith featuring Doris, a cleaning lady that witnesses the divides of a society shaken by Brexit. This series will be composed of a monthly cartoon shedding light on a particular issue around the British society and Brexit from July 2018 till the departure of the UK from the EU in March 2019.
The Chequers summit on 6 July and the subsequent resignation of ministers illustrates how controversial it is to decide whether the UK should share a “common rule book” with the EU after Brexit, or set up its own independent regulators. In this blog, Derek Hill looks at the regulation of medicines and medical devices as examples of the thin margin of action that the UK … Continue reading Can the UK be an independent leading regulator in the development of new medicines and medical devices?